Frieder Bauss

Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

Toshiyuki Yoneda, Akira Sasaki, Colin R. Dunstan et al. · Journal of Clinical Investigation · 1997 · 249 citations · Full text

Medicine, Oncology, Pharmacology +17

BM 21.0955, a potent new bisphosphonate to inhibit bone resorption

R. C. Mühlbauer, Frieder Bauss, Robert Schenk et al. · Journal of Bone and Mineral Research · 1991 · 243 citations

Medicine, Medicinal Chemistry, Bone Metabolism +10

Tumor necrosis factor mediates endotoxic effects in mice

Frieder Bauss, Wulf Dröge, Daniela N. Männel · Infection and Immunity · 1987 · 138 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +14

Osteonecrosis of the Jaw: Effect of Bisphosphonate Type, Local Concentration, and Acidic Milieu on the Pathomechanism

Sven Otto, Christoph Pautke, Christine Opelz et al. · Journal of Oral and Maxillofacial Surgery · 2010 · 138 citations

Medicine, Maxillofacial Surgery, Oral Pathology +15

Ibandronate Reduces Osteolytic Lesions but not Tumor Burden in a Murine Model of Myeloma Bone Disease

Sarah L. Dallas, I. Ross Garrett, Babatunde O. Oyajobi et al. · Blood · 1999 · 136 citations

Medicine, Cancer Biology, Oncology +16